A recent report published on Healio.com reveals that hormone replacement therapy (HRT) in postmenopausal women is associated with an increased risk of gastrointestinal (GI) cancers. The study, which analyzed data from over 70,000 women, found that those who underwent HRT had a higher likelihood of developing GI cancers compared to women who did not receive hormone therapy. The research focused on the three main types of GI cancers: colorectal, liver, and pancreatic cancer. The findings showed that the risk of these cancers was significantly elevated among postmenopausal women using hormone replacement therapy. While previous studies have indicated potential risks associated with HRT, this report adds further evidence linking it specifically to GI cancers. These results have important implications for healthcare providers and women considering hormone replacement therapy. It is crucial for physicians to carefully evaluate the risks and benefits of HRT and discuss alternative treatment options with their patients.

Read More